Web Images Videos Maps News Shopping Gmail more »
Help | Sign in
Go to Google Groups Home
   
Discussions for 3SBio Inc. View all discussions
My starred discussions
My profile

  Upcoming Phase 3 data of Obesity drug
Only 1 message in discussion  - 
Reporting discussion
Messages reported
The group you are posting to is a Usenet group. Messages posted to this group will make your email address visible to anyone on the Internet.
Your reply message has not been sent.
Your post was successful
 
From:
To:
Cc:
Followup To:
Add Cc | Add Followup-to | Edit Subject
Subject:
Validation:
For verification purposes please type the characters you see in the picture below or the numbers you hear by clicking the accessibility icon. Listen and type the numbers you hear
 
ritushreeya  
View profile  
 More options Jun 30, 9:05 am
From: ritushreeya <ritushre...@gmail.com>
Date: Tue, 30 Jun 2009 06:05:11 -0700 (PDT)
Local: Tues, Jun 30 2009 9:05 am
Subject: Upcoming Phase 3 data of Obesity drug
Reply to author | Forward | Print | Individual message | Report this message | Find messages by this author
Small cap company to release Phase 3 data on their Obesity drug.  If
results are good, it will result in huge interest in the company and
its stock.  To read about which company, what drug, how it targets
obesity, how its different from existing drugs targeting obesity,
estimated market penetration of approved, etc., get a FREE report at:
http://www.newbiomedicine.com

    Reply to author    Forward  
You must Sign in before you can post messages.
To post a message you must first join this group.
Please update your nickname on the subscription settings page before posting.
You do not have the permission required to post.

End of messages  

« Newer discussion  -  Phase III trial data of a small cap company's upcoming obesity drug   FDA Decision on approval of a small cap company's drug for Anemia on June 29th  -  Older discussion »




Google Home - Terms of Service - Privacy Policy

©2009 Google